Clark Estates Inc’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-43,000
Closed -$8.22M 113
2019
Q4
$8.22M Hold
43,000
1.26% 19
2019
Q3
$7.24M Hold
43,000
1.19% 19
2019
Q2
$7.2M Sell
43,000
-14,000
-25% -$1.94M 1.15% 19
2019
Q1
$8.35M Hold
57,000
1.29% 19
2018
Q4
$7.62M Sell
57,000
-89,500
-61% -$14.7M 1.22% 21
2018
Q3
$27.9M Sell
146,500
-22,500
-13% -$4.13M 4.19% 5
2018
Q2
$28.2M Buy
169,000
+3,000
+2% +$482K 4.21% 5
2018
Q1
$27.9M Buy
166,000
+45,000
+37% +$7.55M 4.46% 5
2017
Q4
$19.8M Buy
121,000
+66,000
+120% +$11.8M 3.27% 10
2017
Q3
$11.3M Buy
+55,000
New +$12.8M 1.87% 13

Other funds holding AGN

Clark Estates Inc's AGN Position: Q1 2020 in Review

Clark Estates Inc sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 43,000 shares — an estimated $8.22M sold.

Clark Estates Inc first reported a position in AGN in Q3 2017 and held it in 10 quarters. The position peaked at $28.2M in Q2 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Clark Estates Inc reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Clark Estates Inc sold 43,000 Allergan plc shares in Q1 2020, an estimated $8.22M.
  • Clark Estates Inc first reported a position in Allergan plc in Q3 2017 and held it in 10 quarters.
  • Clark Estates Inc's Allergan plc position peaked at $28.2M in Q2 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Clark Estates Inc's 13F filing for Q1 2020, filed 28 Apr 2020.